Clinical Trial Update: A Multicenter, Randomized, Double-Blind Phase 3 Trial of KDF1901 in Patients With Essential Hypertension [Phase 3]

View source ↗

Summary

A multicenter, randomized Phase 3 trial of KDF1901 for essential hypertension has completed, with a status update provided but no efficacy results reported in t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• KDF1901 (KDF1901)

Snippet

Sponsor: Kyungdong Pharmaceutical Co., Ltd. | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED